Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS Coronavirus (SARS-CoV-2) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06920628
What this trial is testing

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Who this might be right for
Long COVIDPost Acute Sequelae of COVID-19
National Institute of Mental Health (NIMH) 60
Early research (Phase 1)Study completedNCT07235137
What this trial is testing

Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults

Who this might be right for
Healthy Participant
Pfizer 12
Testing effectiveness (Phase 2)Looking for participantsNCT07189936
What this trial is testing

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

Who this might be right for
Post-Acute COVID-19 SyndromePostural Tachycardia Syndrome (POTS)SARS CoV 2 Infection+1 more
Vanderbilt University Medical Center 50
Not applicableEnrolling By InvitationNCT07343856
What this trial is testing

Long COVID Diagnostic Reactivity Assesment Test

Who this might be right for
Long COVIDPost-Acute Sequelae of SARS-CoV-2 Infection
Oncology Center,Ministry Of Heath,Uzbekistan 50
Not applicableUnknownNCT04990531
What this trial is testing

Low-field Magnetic Resonance Imaging of Pediatric COVID-19

Who this might be right for
Sars-CoV-2 InfectionLung FibrosisCovid19
University of Erlangen-Nürnberg Medical School 68
Testing effectiveness (Phase 2)Ended earlyNCT04432272
What this trial is testing

ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome (SARS)Coronavirus Infections
Corewell Health East 71
Not applicableStudy completedNCT05747677
What this trial is testing

HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19

Who this might be right for
COVID-19SARS-CoV-2 Infection
Beijing Ditan Hospital 14
Not applicableStudy completedNCT04517630
What this trial is testing

Renal Biomarkers in AKI and COVID-19

Who this might be right for
Coronavirus InfectionCovid19SARS (Severe Acute Respiratory Syndrome)+1 more
Instituto Nacional de Enfermedades Respiratorias 51
Early research (Phase 1)Ended earlyNCT05092581
What this trial is testing

COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2
Not applicableEnded earlyNCT04870411
What this trial is testing

Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics

Who this might be right for
Autoimmune DiseasesInflammatory Disorder
Assistance Publique - Hôpitaux de Paris 78
Not applicableStudy completedNCT04590365
What this trial is testing

Carrageenan Nasal Spray for COVID-19 Prophylaxis

Who this might be right for
COVID-19SARS-CoV 2
Swansea University 480
Not applicableStudy completedNCT04444609
What this trial is testing

PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort

Who this might be right for
COVID-19SARS-CoV 2ARDS, Human+1 more
Imperial College London 161
Not applicableStudy completedNCT04834934
What this trial is testing

Artificial Intelligence - SARS-CoV-2 (COVID-19) Risk Evaluation

Who this might be right for
Covid19
IRCCS San Raffaele 2,000
Not applicableUnknownNCT04527133
What this trial is testing

An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19

Who this might be right for
COVID-19
Aviron LLC 30
Not applicableUnknownNCT05011344
What this trial is testing

Evolution of Protective Immunization Against COVID-19 Among Hospital Workers in Health Care Facilities

Who this might be right for
Covid19
Assistance Publique Hopitaux De Marseille 1,000
Not applicableStudy completedNCT04378452
What this trial is testing

Assessment of the Psycho-social Impact of COVID-19 Outbreak

Who this might be right for
SARS-CoV 2COVID-19Quality of Life+4 more
Fundació Institut Germans Trias i Pujol 56,656
Early research (Phase 1)Study completedNCT04895449
What this trial is testing

Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19

Who this might be right for
Covid19
Universitätsklinikum Hamburg-Eppendorf 43
Not applicableStudy completedNCT05907044
What this trial is testing

Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults

Who this might be right for
COVID-19
Affiliated Hospital of Yunnan University 376
Not applicableStudy completedNCT04932863
What this trial is testing

BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment

Who this might be right for
NeoplasmsCancer, Treatment-Related
Ente Ospedaliero Ospedali Galliera 300
Testing effectiveness (Phase 2)Ended earlyNCT04619706
What this trial is testing

Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19

Who this might be right for
COVID-19
Quantum Biopharma 53
Next Page